indeed, revision of the iCHD iii should be postponed for a certain time interval, so that the classification can be translated into various languages and implemented throughout the world. Fre quent revisions to the classification would have negative effects on implementation, because the users would not have time to get accustomed to the ev er-changing criteria.
a major advantage of the iCHD ii over previous classifications was the addition of an appendix for proposed headache diagnostic criteria that had not been sufficiently validated by research studies. thus, headache diagnoses that were likely to be part of future editions of iCHD could be easily tested by various groups, using uniform criteria. this situation was more desirable than the scenario whereby each research group tested their own definitions of specific headache disorders as, in the latter case, comparisons between the outcomes of various studies were difficult to make. several headache diagnoses mentioned in the appendix of the iCHD ii will probably be incorporated into future revisions of the classification following sufficient scientific testing. unfortunately, the iCHD iii will be flawed if chronic migraine is included in the classifica tion rather than the appendix, as this condition is a compound diagnosis of two types of headache, migraine without aura and tension-type headache. thus, the proposed diagnosis of chronic migraine would break the rules of having explicit, unambiguous and precise diagnostic cri teria and one set of criteria for each type of headache. indeed, further scientific evidence should be provided before these criteria are included into the iCHD iii. Prospective recording in a diagnostic headache diary might be a helpful way of precisely monitor ing various headache characteristics and, hence, improving future headache criteria. 
BraIn IMagIng
Incidental findings: in practice and in person
Judy Illes and Emily Borgelt
Prospective research participants, patients and consumers are faced with a cacophony of information about the risks and benefits of brain scans.
In light of new data on incidental findings, the professional community has a duty to explicitly and systematically encourage questions that promote rational decision-making and informed choice.
in a paper published in august 2009, morris et al. 1 contributed to the conversation about clinically unexpected findings ('incidental findings') on brain mri with a systematic retrospective review and meta-analysis spanning almost 60 years of published litera ture. their review focused on studies of people without neurological symptoms who underwent imaging for the purposes of research, for occupational or clinical screening, or commercially for reassur ance of good brain health. the authors confirmed what many investigators have been reporting for the past 10 years, [2] [3] [4] namely, that clinically significant incidental findings are more common than previously thought (a prevalence of 2-3%, or 1 of every 37 neurologically asymptomatic people scanned), increase in occurrence with age, and are primarily neoplastic and vascular in nature. in addition, high-resolution mri elevates the likelihood of an incidental finding and the risks and benefits associated with that discovery.
the authors also contribute meaningfully to the discussion by pointing out that awareness of unexpected brain disease, such as an unruptured aneurysm, might lead to improved clinical manage ment of risk. in our own examination of incidental findings on functional mri from a health eco nomics perspective, we concluded that, given the varying risks of intra cranial aneurysm between different popula tions, screening strategies must be tailored to the specific characteristics of the prospec tive study participant. 5 For example, before enrollment into a trial, a full clinical examina tion of women who have a positive family history of intra cranial aneurysm is economically indicated. we also demon strated that a review by a non specialist of structural prescans that precede the ac quisition of functional data-a strategy used by many …clinically significant incidental findings are more common than previously thought… www.nature.com/nrneurol news & views research laboratories-is not justifiable from a health economics point of view. overall, and regardless of the population under study, we have suggested, along with morris and colleagues, that disclosure of the possibility of incidental findings belongs in the realm of informed consent. Correctly, morris et al. further conclude from their data that the frequency of occurrence of such findings in the general popula tion is insufficient to justify universal screening.
the work conducted over the past decade on the problem of incidental findings has been rigorous and meritorious. nevertheless, we propose a moratorium on further retro spective studies of the nature described in the morris et al. paper. Despite excellent methods and diverse approaches, such studies are becoming largely redundant. we must now shift our attention to the challenges ahead. two critical concerns, which we will not dwell on here, are incidental findings discovered in banked data, and individual findings that fall outside a normative range yielded by group-averaged functional images. these issues will require substantial time and effort to resolve. we instead focus on a third challenge of equal immediacy and possibly easier tractability: a need for specific direction for study participants, patients and con sumers to enable them to navigate through the labyrinth of information about incidental findings in research, in clinical care, and in the rapidly evolving industry of personalized medicine. reference to prevalence statistics, for example, as we and others have proposed as a minimum criterion for advising people about incidental findings, 6, 7 is not sufficient to meet the requirement of 'informed' in any of these settings.
to support this call to action in the context of a brief commentary, we probed the information available in the public domain about unexpected findings in people presumed to be brain healthy. specifically, we conducted a content analysis of press, blog and other internet coverage of the morris et al. paper. in the period following its publication, we captured 17 distinct articles through Google alerts and a comprehensive sweep of Google search engines (web, news, Blogs and scholar). we coded the articles for type of posting (news article, blog post, organization press release, or live forum), accuracy of article content (proxi mity of the match with the text of the original paper), and accuracy of headline (proximity of the match with conclusions of the paper), using previously established methods. 8 we excluded direct links to the morris et al. paper.
of the 17 postings captured, 13 were news articles, 3 were blog posts, and 1 was a press release. each of these postings reappeared fewer than three times, except for two news articles-"Brain scans often unnecessary, study Finds" and "incidental Findings on Brain mris Pose Dilemma"-which were reposted in full to 9 and 13 sites, respectively, including other news websites, blogs, and a live forum. of the 17 postings, 59% (n = 10) provided a content account that we classified as balanced for accuracy. 53% (n = 9) carried headlines that we classified as sensational, such as "experts issue warning over Private Brain screening tests" and "Health mots do more Harm than Good", promulgating false or hyperbolic notions about the purpose of the morris et al. study and the private sale of brain screening. we found that four postings with sensational headlines actually had accurate content, while two postings with seemingly objective headlines, such as "incidental Findings are Common on Brain mri: meta-analysis", contained erroneous content. also noteworthy was that the type of online source did not predict the objectivity and veracity of reporting; for example, reputable online newspapers were as prone to spinning or hyping the study as were uncurated blogs or live forums.
From this select sample of rapid online communications, we found both objective review and misleading discussion about incidental findings in the brain. Given the increasing breadth of applications of brain imaging, and in light of the fundamental commitment by medical researchers and clinicians to nonmaleficence and respect for persons, the professional community has a duty to ensure that rational decisions can be made amid this cacophony of information. Key issues are continued eligibility in a study or clinical trial, the transfer of information to others, including heath-care providers or others designated to receive medical information, next steps for followup, including complications and cost, and assessment of immediate health and the implications for future health and be havior. at present, information available online to the self-guided user is noisy and unreliable. in any context in which an incidental finding in the brain might become a part of a person's life, questions about anticipating and manag ing such a finding must be explicitly and systematically encouraged.
…we now propose a moratorium on further retrospective studies…
